Abstract:Objective To analyze the serological patterns of both HBsAg and HBsAb positive patients with chronic HBV infection, and to investigate the virus gene sequence variation or missing pre-S/S ifeld for genotyping and in order to explore its clinical signiifcance. Methods Total of 100 cases with chronic HBV infection whom with both HBsAg and HBsAb positive at the same time were screened by enzyme linked immunoabsorbent assay analysis method and the results were reconfirmed by chemiluminessence micro-particle immunoassay. HBV DNA content were detected by real-time lfuorescent quantitative PCR. There were 60 cases with HBV DNA positive and 40 cases with HBV DNA negative. Among the 100 cases, 60 cases with both HBsAg and HBsAb positive as experimental group, and 60 cases with chronic hepatitis B whom with HBsAg (+) and HBsAb (-) as control group. HBV pre-S/S gene sequences and sequencing analysis of the two groups were detected by polymerase chain reaction (PCR) method with in vitro ampliifcation. Compared the two groups of pre-S/S gene variants according to the sequencing results of genetic classiifcation, thus combined with clinical data to explore its clinical signiifcance. Results Among the experimental group, genotypes B were 19 cases and genotype C were 41 cases;among the control group, of genotype B were 18 cases and genotype C were 42 cases. Patients with genotype B were older than cases with genotype C in experimental group (50.0 ± 16.3 vs 34.0 ± 13.4, F=31.6, P=0.0432). The amino acid mutation rate in S area of cased with genotype B and C in experimental group were 10.4%and 21.6%, respectively (F=24.31, P=0.046). The amino acid mutation rate in S area of cases of genotype C in experimental group was 41.6%, which significantly higher than those in control group (3.2%), with significant difference (F=85.68,P=0.006). Conclusions The serum HBV DNA positive rate in patients with HBsAg (+) and HBsAb (+) accompanied by HBeAg (+) increased signiifcantly. The phenomenon of both HBsAg and HBsAb positive genetic mutations and pre-S/S area has signiifcant relevance, while the mutation rate of genotype C higher than that of genotype B.

Relationship Between Serological Markers,Pre-S1Protein and HBV-DNA in Patients with Hepatitis B

Relativity among PreS1-antigen,HBV Markers and HBV-DNA

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Characteristics of patients with concurrent HBsAg and HBsAb in serum

Study on Associations Between HBV DNA and Pre-S1 Antigen and Serum Markers of HBV

Analysis of the Joint Inspection of PreS1 Antigen of Hepatitis B and Hepatitis B Serum Markers

Analysis of Correlation Between the PreS1-Ag and HBV-DNA of the Patients with Hepatitis B

Correlation between pre-S1 antigen and HBV-DNA, HBeAg in hepatitis B patients

Relationship between HBV DNA and serum markers

Value of Pre S1 Protein in Diagnosis of HBV Infection

Prediction of HBV-DNA level by co-detection of serum PreS1 and HBeAg in chronic HBV-carriers

Serological Markers and HBV-DNA in HBV Carriers with Rare Serological Pattern of Negative HBsAg and Positive preS1Ag

Evaluation on the correlation between HBV-DNA and serum HBV-LP of patients with hepatitis B and its clinical application

Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or Without Hepatitis.

Serological Analysis of Large Protein in Sera of HBeAb-positive Patients with Hepatitis B

Study on the serology anomaly pattern of HBsAg and HBsAb positive at the same time of patients with HBV infection

Serum HBeAg and HBV DNA Levels Are Not Always Proportional and Only High Levels of HBeAg Most Likely Correlate with High Levels of HBV DNA: A Community-Based Study.

Relationship of Concentrations of HBeA G with HBV-DNA, ALT and ADA in Sera of Patients with Chronic Hepatitis B

Study on relationship between serum HBeAg mode and HBV DNA level of patients infected with HBV

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Compare the Relationship Between HBV Immunoiogical Marker and HBV-DNA Concentrations